WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011016366) CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/016366    International Application No.:    PCT/JP2010/062608
Publication Date: 10.02.2011 International Filing Date: 27.07.2010
IPC:
A61K 31/121 (2006.01), A23K 1/16 (2006.01), A23L 1/30 (2006.01), A23L 2/00 (2006.01), A61P 9/10 (2006.01)
Applicants: National University Corporation Hokkaido University [JP/JP]; Kita 8-jyo Nishi 5-chome, Kita-ku, Sapporo-shi, Hokkaido 0600808 (JP) (For All Designated States Except US).
SAPPORO BREWERIES LIMITED [JP/JP]; 20-1, Ebisu 4-chome, Shibuya-ku, Tokyo 1508522 (JP) (For All Designated States Except US).
CHIBA Hitoshi; (For US Only).
HIRATA Hiroshi [JP/JP]; (JP) (For US Only).
TAKAZUMI Koji [JP/JP]; (JP) (For US Only)
Inventors: CHIBA Hitoshi; .
HIRATA Hiroshi; (JP).
TAKAZUMI Koji; (JP)
Agent: HASEGAWA Yoshiki; SOEI PATENT AND LAW FIRM, Marunouchi MY PLAZA (Meiji Yasuda Life Bldg.) 9th fl., 1-1, Marunouchi 2-chome, Chiyoda-ku, Tokyo 1000005 (JP)
Priority Data:
2009-182674 05.08.2009 JP
2010-105403 30.04.2010 JP
Title (EN) CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR
(FR) INHIBITEUR DE LA PROTÉINE DE TRANSFERT D'ESTER DE CHOLESTÉROL
(JA) コレステロールエステル転送タンパク質阻害剤
Abstract: front page image
(EN)Disclosed is a cholesterol ester transfer protein (CETP) inhibitor which contains a compound represented by general formula (1) as an active ingredient. (In the formula, R1 represents a hydrogen atom or an alkyl group having 1-5 carbon atoms, and R2 represents a dimethylallyl group or a geranyl group.)
(FR)L'invention porte sur un inhibiteur de la protéine de transfert d'ester de cholestérol (CETP) qui contient un composé représenté par la formule générale (1) comme principe actif. (Dans la formule, R1 représente un atome d'hydrogène ou un groupe alkyle ayant 1-5 atomes de carbone et R2 représente un groupe diméthylallyle ou un groupe géranyle).
(JA) 本発明は、一般式(1)で表される化合物を有効成分として含有するコレステロールエステル転送タンパク質(CETP)阻害剤。 [式中、Rは、水素原子又は炭素数1~5のアルキル基を表し、Rは、ジメチルアリル基又はゲラニル基を表す。]
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)